A friend and former co-worker of mine has the most adorable daughters. The two little girls love to play outside; riding bikes, playing on the swingset, swimming, and generally having lots of fun together. They laugh a lot, share hugs and kisses, and, yes, occasionally bicker. They
are very much like any other sisters except that the older one, Chloe, is affected by Angelman Syndrome.
Chloe can walk without assistance, but has a stiff, jerky gait. She can communicate through sound, but can only say a very small number of words. Typical of Angelman children, Chloe smiles a lot and laughs excessively. She is very affectionate, but doesn’t know her own strength. Chloe needs a good deal of medical attention and will permanently require care.
Angelman Syndrome (AS) is a neuro-genetic disorder that occurs in 1 in 15,000 live births. AS is often misdiagnosed as cerebral palsy or autism. Characteristics of AS include; developmental delay, lack of speech, seizures, and walking and balance disorders. Individuals with Angelman Syndrome will require life-long care.
The Angelman Syndrome Foundation seeks to improve the lives of individuals with Angelman Syndrome (AS), and their families. Through education, information exchange and support for research individuals, families, healthcare and education professionals benefit from a greater understanding of AS and improved therapies and treatment. Our ultimate goal is prevention and cure.
Chloe and her family will be participating in the 2011 Angelman Syndrome Foundation Walk in Cincinnati on May 21. Last year, the national walk raised over $800,000 for research. If you would like to find a walk event near you and register, click HERE.
If you would like to donate to Chloe’s fundraising efforts, click HERE. Any amount is helpful and much appreciated. I gave and I hope you will, too.
Imagine the possibilities for Chloe and other little angels like her.
Note: It is always wise to research before donating. The Angelman Syndrome Foundation has a four-star rating from Charity Navigator. Read more HERE.


